Neuroendocrine tumor liver metastases : use of dynamic contrast-enhanced MR imaging to monitor and predict radiolabeled octreotide therapy response

Purpose: To evaluate dynamic contrast-enhanced (DCE) magnetic resonance (MR) imaging for monitoring and assessing treatment response in patients with neuroendocrine liver metastases treated using yttrium 90 (90Y)-labeled octreotide (90Y-DOTATOC). Materials and Methods: The study was approved by...

Full description

Bibliographic Details
Main Authors: Miyazaki, K., Orton, M. R., Davidson, R. L., d'Arcy, J. A., Lewington, V., Koh, T. S., Thng, C. H., Leach, M. O., Collins, D. J., Koh, D.-M.
Other Authors: School of Electrical and Electronic Engineering
Format: Journal Article
Language:English
Published: 2013
Subjects:
Online Access:https://hdl.handle.net/10356/84807
http://hdl.handle.net/10220/12276